A new study examined how treatments for atrial fibrillation (Afib) affected cognitive decline and frailty. Treating heart rate compared to rhythm was linked to a greater rate of cognitive decline, the ...

March 5, 2004 — The results of a substudy from the Rate Control Versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) trial find that patients with persistent atrial fibrillation ...

Atrial fibrillation (AF) in older adults extends well beyond stroke prevention. Advancing age is the strongest demographic driver of AF prevalence and ...

For patients with newly diagnosed atrial fibrillation, a quality improvement initiative improved access to specialist care ...

COMPASS presents a “scalable framework” for other centers that want to improve AF care, but additional efforts are needed.

Old concerns about the safety of rhythm control drugs for atrial fibrillation (Afib or AF) resurfaced in a contemporary large Korean population-based study. Afib patients prescribed antiarrhythmic ...

The heart rhythm disorder called atrial fibrillation (AFib) can affect people of any age, but is most common in older adults. It may start with a rapid heartbeat, a fluttering feeling in a person’s ...

A recent randomized trial in Czechia tested the premise that lifestyle modification and use of antiarrhythmic drugs was as effective as catheter ablation (CA) to treat atrial fibrillation (AF). The ...

Atrial fibrillation (AFib) can lead to blood clots, stroke, heart failure, and other heart-related complications. New consumer patient research from the Dallas-based American Heart Association found ...

What changed?: The COMPASS initiative boosted early rhythm control use in AF from 28.8% to 32.8% within six months of diagnosis. Specialist access up: Referrals to electrophysiologists rose from 22.6% ...